Product Specifications
| Catalog Number | BIC-2096E |
|---|---|
| Target | Interleukin-13 |
| Target Symbol | IL13 |
| Endotoxin | ≤10 EU/mg by the LAL method. |
| Formulation | Lyophilized |
| Buffer | Lyophilized from a 0.22 μm-filtered solution containing PBS, 5% Mannitol and 0.01% Tween 80, pH 7.4. |
| Reconstitution | It is recommended to redissolve in sterile deionized water. |
| Storage & Stability | 36 months at 2°C to 8°C in lyophilized state; 6 months at -20°C to -80°C under sterile conditions after reconstitution; 7-10 days at 2°C to 8°C under sterile conditions after reconstitution; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Accession | P35225 |
| Alternative Names | Interleukin-13; IL-13 |
Bioactivity
Human IL-13(Cat. No. BIC-2096E) measured in a cell proliferation assay using TF-1 cells. The ED50 is ≤1.0 ng/mL，corresponding to a specific bioactivity of ≥1×106 U/mg. The bioactivity of IL-13(Cat. No. BIC-2096E) was equivalent to other competing products.
Quality Data
Recombinant Human IL-13 (Cat. No. BIC-2096E) SDS-PAGE under reducing (R) & Non-reducing conditions.
